首页 | 本学科首页   官方微博 | 高级检索  
   检索      

猴头菌粉与5-氨基水杨酸联用抑制小鼠急性溃疡性结肠炎并提高肠道共生菌Parabacteroides distasonis丰度
引用本文:郭琳,耿燕,岳远佳,任怡琳,李华钟,许正宏.猴头菌粉与5-氨基水杨酸联用抑制小鼠急性溃疡性结肠炎并提高肠道共生菌Parabacteroides distasonis丰度[J].菌物学报,2021,40(5):1148-1159.
作者姓名:郭琳  耿燕  岳远佳  任怡琳  李华钟  许正宏
作者单位:1.江南大学生物工程学院 工业生物技术教育部重点实验室 江苏 无锡 2141222.江南大学粮食发酵工艺与技术国家工程实验室 江苏 无锡 2141223.江南大学 江苏省生物活性产品加工技术工程研究中心 江苏 无锡 2141224.江南大学药学院 江苏 无锡 214122
基金项目:中国博士后科学基金资助项目(2018M640455);江苏省博士后科研资助(2018K029B);中央高校基本科研业务费专项资金(JUSRP22029);中央高校基本科研业务费专项资金(JUSRP21824);中央高校基本科研业务费专项资金(JUSRP22047);国家轻工技术与工程一流学科自主课题资助(LITE2018-11)
摘    要:猴头菌Hericium erinaceus是一种药食同源真菌,广泛应用于治疗胃肠道疾病,可采用液态发酵技术规模化量产获得菌丝体粉。本研究旨在分析猴头发酵菌粉(HE,300mg/kg/d)与5-氨基水杨酸(5-aminosalicylic acid,5-ASA,150mg/kg/d)联用对葡聚糖硫酸钠(dextran sodium sulfate,DSS)诱导的小鼠结肠炎的治疗作用。HE和5-ASA能够减轻小鼠急性溃疡性结肠炎症状,包括减轻体重的降低率和疾病活动指数评分(DAI)。HE和5-ASA联用可以显著抑制小鼠结肠组织炎症,通过降低肿瘤坏死因子-α(Tnf-α)和白细胞介素-β(Il-β)基因的表达。此外,利用16S rRNA基因测序技术对小鼠盲肠微生物群落组成及结构进行分析。HE与5-ASA联用可以重塑肠道微生态环境,并显著提高狄氏副拟杆菌Parabacteroides distasonis相对丰度。人体粪便体外发酵结果证实HE与5-ASA可以增加P. distasonis。综上,HE与5-ASA联用可有效抑制小鼠结肠炎症水平,并调节肠道微生物,可能是通过增加P. distasonis起作用。

关 键 词:结肠炎  肠道菌群  猴头菌  5-氨基水杨酸  狄氏副拟杆菌  
收稿时间:2020-08-17

Combination of dried powder of Hericium erinaceus mycelia and 5-aminosalicylic acid for treatment of acute ulcerative colitis and increase in abundance of gut commensal Parabacteroides distasonis
Authors:GUO Lin  GENG Yan  YUE Yuan-Jia  REN Yi-Lin  LI Hua-Zhong  XU Zheng-Hong
Institution:1. The Key Laboratory of Industrial Biotechnology, Ministry of Education; School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, China2. National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi, Jiangsu 214122, China3. Jiangsu Engineering Research Center for Bioactive Products Processing Technology, Jiangnan University, Wuxi, Jiangsu 214122, China4. School of Pharmaceutical Sciences, Jiangnan University, Wuxi, Jiangsu 214122, China
Abstract:Hericium erinaceus is an edible and medicinal fungus, which has been used to treat gastrointestinal disorders and the dried mycelial product can be obtained by expended submerged culture. The effect on the gut microbiota community of H. erinaceus has not been investigated thoroughly. In this study, the treatment effect of dried powder of the mycelia of H. erinaceus (HE, 300mg/kg/d) combined with the gold standard drug 5-aminosalicylic acid (5-ASA, 150mg/kg/d) on dextran sodium sulfate (DSS)-induced colitis in mice was evaluated. The result indicated that HE or 5-ASA attenuated acute colitis evidenced by the reduction of body weight loss and DAI score. The HE and 5-ASA combination treatment significantly inhibited the inflammatory response by lowering tumor necrosis factor (Tnf-α) and interleukin-β (Il-β) gene expression in colon tissues. 16S rRNA gene sequencing revealed that gut microbiota composition in mice was changed by the combination treatment, and the richness of colonic microbes increased and intestinal micro-ecology rebalanced, resulting in an increase of Parabacteroides distasonis in vivo. In vitro fermentation using human fecal as inoculum further demonstrated that HE and 5-ASA increased the abundance of P. distasonis. In conclusion, combination usage of HE with 5-ASA could effectively inhibit the inflammatory response and modulate gut microbiota in colitis probably via raising the abundance of P. distasonis.
Keywords:colitis  gut microbiota  Hericium erinaceus  5-aminosalicylic acid  Parabacteroides distasonis  
本文献已被 万方数据 等数据库收录!
点击此处可从《菌物学报》浏览原始摘要信息
点击此处可从《菌物学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号